Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

22.20 +0.20 (+0.91%)

Streaming Delayed Price Updated: 11:53 AM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	648,836
Open	21.96
Bid (Size)	22.18 (200)
Ask (Size)	22.21 (300)
Prev. Close	22.00
Today's Range	21.82 - 22.36
52wk Range	10.41 - 129.84
Shares Outstanding	93,148,652
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Is SRPT Stock Falling Today? ↗

December 11, 2025

Sarepta Therapeutics announced a debt refinancing plan totaling about $291 million.

Via Stocktwits

Sarepta Therapeutics Announces Refinancing of Approximately $291 Million of 1.25% Convertible Senior Notes due 2027

December 11, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Performance

YTD	-82.1%	-82.1%
1 Month	+17.4%	+17.4%
3 Month	+23.8%	+23.8%
6 Month	+17.0%	+17.0%
1 Year	-81.6%	-81.6%

More News

Dyne Therapeutics (DYN) Navigates a Paradoxical Day: Positive Clinical Data Overshadowed by Dilution Fears

December 09, 2025

Via MarketMinute

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗

December 02, 2025

Via Investor's Business Daily

Sarepta Wins FDA Approval To Begin Study On Reducing Liver Injury Risk With Elevidys ↗

November 25, 2025

Via Stocktwits

Sarepta Announces Approval to Begin ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

November 25, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1

November 24, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Tech Edges Up Ahead Of Nvidia's Earnings, Bitcoin Sinks Below $90,000: What's Moving Markets Wednesday? ↗

November 19, 2025

Via Benzinga

Sarepta Stock Slides Premarket After New FDA Warning Shrinks Market For Its $3.2M DMD Gene Therapy ↗

November 17, 2025

Via Stocktwits

2 Beaten-Down Stocks to Avoid Right Now ↗

November 15, 2025

Via The Motley Fool

Sarepta Shares Jump After FDA Approves Updated Elevidys Label ↗

November 14, 2025

Via Benzinga

Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information

November 14, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 11, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

Analyst Ratings Send Ripples Through Markets: Sarepta's Resilience vs. Pinterest's Plunge

November 05, 2025

Via MarketMinute

This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

November 05, 2025

Via Benzinga

Sarepta Therapeutics Shares Plummet as Key DMD Treatments Miss Primary Endpoint in Late-Stage Trial

November 04, 2025

Via MarketMinute

Which stocks are experiencing notable movement on Tuesday? ↗

November 04, 2025

Via Chartmill

Gold Falls Over 1%; Uber Shares Decline After Q3 Results ↗

November 04, 2025

Via Benzinga

Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance ↗

November 04, 2025

Via Benzinga

Tuesday's session: top gainers and losers ↗

November 04, 2025

Via Chartmill

Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It ↗

November 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 04, 2025

Via Benzinga

These stocks are gapping in today's session ↗

November 04, 2025

Via Chartmill

Frequently Asked Questions

Is Sarepta Therapeutics, Inc. - Common Stock publicly traded?

Yes, Sarepta Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Sarepta Therapeutics, Inc. - Common Stock trade on?

Sarepta Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sarepta Therapeutics, Inc. - Common Stock?

The ticker symbol for Sarepta Therapeutics, Inc. - Common Stock is SRPT on the Nasdaq Stock Market

What is the current price of Sarepta Therapeutics, Inc. - Common Stock?

The current price of Sarepta Therapeutics, Inc. - Common Stock is 22.20

When was Sarepta Therapeutics, Inc. - Common Stock last traded?

The last trade of Sarepta Therapeutics, Inc. - Common Stock was at 12/24/25 11:53 AM ET

What is the market capitalization of Sarepta Therapeutics, Inc. - Common Stock?

The market capitalization of Sarepta Therapeutics, Inc. - Common Stock is 2.07B

How many shares of Sarepta Therapeutics, Inc. - Common Stock are outstanding?

Sarepta Therapeutics, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.